| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 08/04/2005 | CA2552754A1 Frequency assisted transdermal agent delivery method and system |
| 08/04/2005 | CA2547757A1 Monoparamunity inducers based on attenuated rabbit myxoma viruses |
| 08/03/2005 | EP1559795A2 Neisseria genomic sequences and methods of their use |
| 08/03/2005 | EP1559778A1 Proliferation of hepatocyte precursors |
| 08/03/2005 | EP1559777A1 Process for maturating small heptocyte-rich colonies into liver tissue |
| 08/03/2005 | EP1559726A2 Growth differentiation factor-10 |
| 08/03/2005 | EP1559429A2 Anti-aging agent |
| 08/03/2005 | EP1559328A1 Fungal feeds for aquaculture and agriculture |
| 08/03/2005 | EP1559327A1 Bacterial feeds for aquaculture and agriculture |
| 08/03/2005 | EP1558282A2 Anti-cancer and anti-infectious disease compositions and methods for using same |
| 08/03/2005 | EP1558281A1 Method for inhibiting yeast growth |
| 08/03/2005 | EP1558223A2 Dosage form having an inner core and at least two coating layers |
| 08/03/2005 | EP1558086A2 Cell targeting methods and compositions |
| 08/03/2005 | EP1558085A1 Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer |
| 08/03/2005 | EP1196439B1 Compounds exhibiting an antibiotic activity |
| 08/03/2005 | EP0815231B1 Use of neuronal apoptosis inhibitor protein (naip) |
| 08/03/2005 | EP0755259B1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON |
| 08/03/2005 | EP0742834B2 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell |
| 08/03/2005 | EP0702719B1 Process for the sterilization of biological compositions and the product produced thereby |
| 08/03/2005 | CN1650021A Stable adenoviral vectors and methods for propagation thereof |
| 08/03/2005 | CN1650020A Means and methods for the production of adenovirus vectors |
| 08/03/2005 | CN1650015A DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof |
| 08/03/2005 | CN1650014A Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 08/03/2005 | CN1649998A Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering |
| 08/03/2005 | CN1649968A A natural non-toxic fluorescent protein dye from a non-bioluminescent marine invertebrate, compositions containing the said dye and its uses |
| 08/03/2005 | CN1649900A Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 08/03/2005 | CN1649644A Compositions and methods for treatment of body weight conditions with milk minerals and casein fractions |
| 08/03/2005 | CN1649641A System and method for forming a non-ablative cardiac conduction block |
| 08/03/2005 | CN1649622A DNA vaccine against proliferating endothelial cells and methods of use thereof |
| 08/03/2005 | CN1649621A Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 08/03/2005 | CN1648134A Dog intravenous injection albumin, its preparing method and dog intravenous injection albumin preparation |
| 08/03/2005 | CN1647801A Staphylococcus aureus metabolic product medicine oral preparation and its use |
| 08/03/2005 | CN1647800A Globefish oil preparation and its preparing method |
| 08/03/2005 | CN1647799A Toad extract liposome preparation for injection and its preparing method |
| 08/03/2005 | CN1213143C Pharmacentical use of homoeotic hematoietic system reconstitution cell |
| 08/03/2005 | CN1212866C Biodegradable polymer scaffold structure |
| 08/03/2005 | CN1212857C Osteodynia alleviating and wind dispelling liniment |
| 08/03/2005 | CN1212852C Medicine for curing cervical spondylopathy |
| 08/03/2005 | CN1212850C Oral liquid for resolving embolism |
| 08/03/2005 | CN1212849C Combinee supercritical and auxiliary microwave extraction process of separating effectrive bee glue components |
| 08/02/2005 | US6924415 Identified as a target for therapeutic intervention due to its role in molecular events that lead to or contribute to cardiac hypertrophy and/or dilated cardiomyopathy |
| 08/02/2005 | US6924370 Crosslinkable macromers |
| 08/02/2005 | US6924142 Multipotent neural stem cells are proliferated in the presence of growth factors and erythropoietin which induces the generation of neuronal progenitor cells |
| 08/02/2005 | US6924141 Inducing the effects of promoted signal transduction with protein and lithium chloride or mimicking via administration of agent that inhibits either catenin phosphorylation or kinase |
| 08/02/2005 | US6924137 virus is propagated in culture media at a cultivation temperature below 37 degrees C., wherein the chordopoxvirus is selected from Avipoxvirus and modified vaccinia virus Ankara |
| 08/02/2005 | US6923972 Methods for use of genetically modified tumor-targeted bacteria with reduced virulence |
| 08/02/2005 | US6923959 Method of pre-inducing a state of immune tolerance before organ transplantation |
| 08/02/2005 | US6923958 For immunizing a mammal against cancer cells that present a carcinoembryonic antigen (CEA) |
| 08/02/2005 | CA2148934C Targetable vector particles |
| 07/30/2005 | CA2495497A1 Compositions for eliciting immune response and methods for using same |
| 07/28/2005 | WO2005068614A2 Preparation of fibroblast-populated connective tissue substitute |
| 07/28/2005 | WO2005068612A2 Human hepatic progenitor cells and methods of use thereof |
| 07/28/2005 | WO2005068498A2 Human therapeutic cells secreting nerve growth factor |
| 07/28/2005 | WO2005067981A1 Gene therapy for tumor using minus-strand rna virus vector encoding immunostimulating cytokine |
| 07/28/2005 | WO2005067962A2 Composition derived from milk goat comprising growth factors and oligosaccharides |
| 07/28/2005 | WO2005067949A1 Antiviral preparation |
| 07/28/2005 | WO2005067948A2 Biological medicine for treating various diseases caused by various virus, bacterial infection |
| 07/28/2005 | WO2005067942A1 Glycosaminoglycan peptides derived from connective tissues and use thereof in the prevention of arthritis and other degenerative medical conditions |
| 07/28/2005 | WO2005067918A1 Active oxygen eliminator originating in natural material and use of the same |
| 07/28/2005 | WO2005056780A3 Cell culture with nm23, cell culture media comprising nm23 and therapeutic use of cells cultured in the presence of nm23. |
| 07/28/2005 | WO2005056024A9 Methods of enhancing stem cell engraftment |
| 07/28/2005 | WO2005054446A3 Use of polysulphated alginate in cellular matrices |
| 07/28/2005 | WO2005051433B1 Method for treating human tumor cells with a newcastle disease virus strain and a chemotherapeutic agent |
| 07/28/2005 | WO2005041942A9 Three-dimensional mammalian ovarian follicular cell and ovarian follicle culture systems in a biocompatible matrix |
| 07/28/2005 | WO2004089189A3 Minimally-invasive imaging of viral gene therapy and presurgical applications thereof |
| 07/28/2005 | WO2004033620A3 Methods and compositions for therapeutic use of rna interference |
| 07/28/2005 | WO2002055010A3 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/28/2005 | US20050166274 Compositions and methods for the diagnosis and treatment of tumor |
| 07/28/2005 | US20050164388 Method of isolating epithelial cells, method of preconditioning cells, and methods of preparing bioartificial skin and dermis with the epithelial cells and preconditioned cells |
| 07/28/2005 | US20050164383 Undifferentiated progenitor cells invitro differentiation into somatic cell tissues; transplantation and treatment of congenital disorders |
| 07/28/2005 | US20050164382 Differentiation protocol for making human cardiomyocytes |
| 07/28/2005 | US20050164378 Using schwann cells as tools to establish propagating colonies of basal membranes muscles tissue; regenerative medicine; tissue engineering |
| 07/28/2005 | US20050164368 Transgenic, grampositive bacteria comprising expression vector coding viricidal agent for use in treatment and prevention of gastrointestinal disorders in infants |
| 07/28/2005 | US20050163888 dairy products containing Lactobacillus gasseri used for prophylaxis and/or therapy of gastrointestinal disorders such as ulcers |
| 07/28/2005 | US20050163878 Therapeutic agent of skin diseases |
| 07/28/2005 | US20050163802 medicament comprising a biomass obtained from a methanotrophic-bacterium containing culture; immunostimulatory; pig, poultry or fish |
| 07/28/2005 | US20050163794 Immunological herpes simplex virus antigens and methods for use thereof |
| 07/28/2005 | US20050163790 Method of treatment and agents useful for same |
| 07/28/2005 | US20050163780 Administering antagonist of a GP39, selected from an antibody which specifically bind GP39, soluble CD40 and soluble CD40 fusion proteins |
| 07/28/2005 | US20050163778 Extracorporeal photopheresis in combination with anti-TNF treatment |
| 07/28/2005 | US20050163773 Methods and pharmaceutical compositions for dopaminergic modulation of t-cell adhesion and activity |
| 07/28/2005 | US20050163763 Induction of beta cell differentiation in human cells by stimulation of the GLP-1 receptor |
| 07/28/2005 | US20050163760 sustained delivery of a molecule to the central nervous system; bioavailability; population of cells enriched in hematopoietic stem or progenitor or stem cells capable of migrating to the CNS upon administration |
| 07/28/2005 | US20050163759 Compositions and methods for ex vivo preservation of blood vessels for vascular grafts using inhibitors of type I and/or type II phosphodiesterases |
| 07/28/2005 | US20050163757 Anti-microbial biotherapeutic agents: alternatives to conventional pharmaceutical antibiotics |
| 07/28/2005 | US20050163753 Stable adenoviral vectors and methods for propagation thereof |
| 07/28/2005 | US20050163750 Methods of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby |
| 07/28/2005 | US20050163744 Novel method for down-regulation of amyloid |
| 07/28/2005 | CA2553377A1 Gene therapy for tumors using minus-strand rna viral vectors encoding immunostimaulatory cytokines |
| 07/28/2005 | CA2553334A1 Preparation of fibroblast-populated connective tissue substitute |
| 07/28/2005 | CA2553303A1 Human hepatic progenitor cells and methods of use thereof |
| 07/27/2005 | EP1557462A2 Transplant acceptance inducing cells of monocytic origin and their preparation and use |
| 07/27/2005 | EP1557177A1 Antigen for transcutaneous immunisation |
| 07/27/2005 | EP1557172A1 Method and composition for regulating the activity of regulatory t cells |
| 07/27/2005 | EP1557171A1 Rabbit skin comprising biological active substance and its use |
| 07/27/2005 | EP1556487A2 Transplantable cell |
| 07/27/2005 | EP1556063A2 Retinal pigment epithelial cell cultures on amniotic membrane and transplantation |
| 07/27/2005 | EP1556062A2 Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity |
| 07/27/2005 | EP1287004B1 Synthetic process for the manufacture of an ecteinascidin compound |
| 07/27/2005 | EP0973564B1 Method for separation of particles |